Rhythm Biosciences Limited

Equities

RHY

AU000000RHY2

Biotechnology & Medical Research

Delayed Australian S.E. Other stock markets 01:58:11 2024-04-24 am EDT			5-day change	1st Jan Change
0.084 ^AUD	-7.69%		-8.70%	-37.78%

Apr. 24	Rhythm Biosciences Appoints CEO; Shares Down 3%	MT
Mar. 21	Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3%	MT

Rhythm Biosciences Limited Reports Earnings Results for the Full Year Ended June 30, 2021

August 31, 2021 at 03:19 am EDT

Rhythm Biosciences Limited announced earnings results for the full year ended June 30, 2021. For the full year, the company announced net loss was AUD 6.612 million compared to AUD 4.022 million a year ago. Basic loss per share from continuing operations was AUD 0.0357 compared to AUD 0.0399 a year ago.

Latest news about Rhythm Biosciences Limited

Rhythm Biosciences Appoints CEO; Shares Down 3%	Apr. 23	MT
Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3%	Mar. 20	MT
Rhythm Biosciences Limited(ASX:RHY) dropped from S&P/ASX All Ordinaries Index	Mar. 17	CI
Rhythm Biosciences Limited(ASX:RHY) dropped from S&P/ASX Emerging Companies Index	Mar. 17	CI
Rhythm Biosciences Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28	CI
Rhythm Biosciences Seeks to Raise AU$6.6 Million Via Rights Offer; Shares Fall 29%	Feb. 09	MT
Rhythm Biosciences Limited Announces Resignation of Rachel David as Non-Executive Director	Dec. 28	CI
Rhythm Biosciences Ltd Announces the Appointment of James Barrie as Joint Company Secretary, Effective 1 January 2024	Dec. 13	CI
Rhythm Biosciences Identifies Lung Cancer Biomarkers from Blood Samples; Shares Fall 6%	Nov. 23	MT
Rhythm Biosciences Limited Announces Resignation of Paul Smith as CFO	Nov. 15	CI
Rhythm Biosciences Limited Announces Executive Changes	Nov. 15	CI
Rhythm Biosciences Receives First Tranche of R&D Tax Rebate	Nov. 14	MT
Rhythm Biosciences' Breast Cancer Diagnostic Test Shows Positive Results	23-09-22	MT
Rhythm Biosciences Joins Forces to Automate Cancer Test Kit	23-09-13	MT
Rhythm Biosciences Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
Rhythm Biosciences Appoints Director to Newly Created Deputy Chair Role	23-07-04	MT
Rhythm Biosciences Signs Deal for UK Entry of Cancer Test	23-05-24	MT
Rhythm Biosciences Secures UK Certification for Diagnostic Test; Shares Surge 89%	23-05-17	MT
Rhythm Biosciences CEO Steps Down; Shares Slump 13%	23-04-19	MT
Rhythm Biosciences Limited Announces Management Changes	23-04-18	CI
Rhythm Biosciences Ltd Announces Executive Changes	23-04-18	CI
Rhythm Biosciences Pulls Out TGA Submission for Colorectal Cancer Diagnostic Kit	23-03-06	MT
Rhythm Biosciences Limited Provides Update to TGA Submission for ColoSTAT® Test-Kit	23-03-05	CI
Rhythm Biosciences Shares Suspended from Australian Bourse	23-03-03	MT
Rhythm Biosciences Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-22	CI

Chart Rhythm Biosciences Limited

Duration

Period

More charts

Company Profile

Rhythm Biosciences Limited is an Australia-based medical diagnostics company. The Company is engaged in the development and commercialization of Australian medical diagnostics technology for sale in domestic and international markets. The Companyâs ColoSTAT a blood-base cancer test, designed for the early detection of colorectal cancer, has been developed initially as an alternative screening test for individuals unable to or unwilling to use available screening modalities. ColoSTAT is indicated to screen adults, aged 40 to 85, at average risk for developing Colorectal Cancer (CRC). The test-kit measures five specific biomarkers in the blood that either increase or decrease in quantity when CRC tumors are present.

Sector

Biotechnology & Medical Research

Calendar

2024-08-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
RHYTHM BIOSCIENCES LIMITED	-37.78%	14.51M
EXACT SCIENCES CORPORATION	-14.52%	11.53B
IOVANCE BIOTHERAPEUTICS, INC.	+44.03%	3.31B
GUARDANT HEALTH, INC.	-33.09%	2.11B
BGI GENOMICS CO., LTD.	-18.60%	2.05B
VERACYTE, INC.	-27.59%	1.49B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+17.10%	1.02B
SEEGENE, INC.	-3.06%	741M
CAREDX, INC	-33.50%	426M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-46.94%	374M

Bio Diagnostics & Testing